Hcr Wealth Advisors Amgen Inc Transaction History

Hcr Wealth Advisors

$757 Million
Q3 2024

A detailed history of Hcr Wealth Advisors transactions in Amgen Inc stock. As of the latest transaction made, Hcr Wealth Advisors holds 4,742 shares of AMGN stock, worth $1.34 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares

4,742

Previous 4,761 0.4%

Holding current value

$1.34 Million

Previous $1.49 Million 2.69%

% of portfolio

0.2%

Previous 0.21%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 10, 2024	SELL	$309.38 - $337.38 $5,878 - $6,410	-19 Reduced 0.4%	4,742 $1.53 Million
Q2 2024 Aug 06, 2024	BUY	$262.75 - $319.31 $39,938 - $48,535	152 Added 3.3%	4,761 $1.49 Million
Q1 2024 May 10, 2024	SELL	$268.87 - $324.56 $13,443 - $16,228	-50 Reduced 1.07%	4,609 $1.31 Million
Q4 2023 Feb 09, 2024	BUY	$255.7 - $288.46 $55,998 - $63,172	219 Added 4.93%	4,659 $1.34 Million
Q3 2023 Oct 20, 2023	SELL	$218.65 - $271.46 $1,530 - $1,900	-7 Reduced 0.16%	4,440 $1.19 Million
Q4 2022 Feb 13, 2023	SELL	$229.03 - $291.01 $22,903 - $29,101	-100 Reduced 2.2%	4,447 $1.17 Million
Q1 2022 May 05, 2022	SELL	$219.27 - $242.57 $46,046 - $50,939	-210 Reduced 4.41%	4,547 $1.1 Million
Q4 2021 Feb 04, 2022	BUY	$198.88 - $227.6 $2,187 - $2,503	11 Added 0.23%	4,757 $1.07 Million
Q3 2021 Nov 02, 2021	BUY	$212.27 - $248.7 $87,030 - $101,967	410 Added 9.46%	4,746 $1.01 Million
Q2 2021 Jul 21, 2021	SELL	$233.58 - $259.14 $37,372 - $41,462	-160 Reduced 3.56%	4,336 $1.06 Million
Q1 2021 May 13, 2021	SELL	$221.91 - $258.6 $155,337 - $181,020	-700 Reduced 13.47%	4,496 $1.12 Million
Q4 2020 Feb 04, 2021	SELL	$216.38 - $257.67 $4,111 - $4,895	-19 Reduced 0.36%	5,196 $1.2 Million
Q3 2020 Nov 05, 2020	SELL	$234.65 - $260.95 $122,018 - $135,694	-520 Reduced 9.07%	5,215 $1.33 Million
Q2 2020 Jul 30, 2020	BUY	$197.81 - $242.74 $15,429 - $18,933	78 Added 1.38%	5,735 $1.45 Million
Q1 2020 May 08, 2020	SELL	$182.24 - $241.7 $72,713 - $96,438	-399 Reduced 6.59%	5,657 $1.15 Million
Q4 2019 Feb 07, 2020	BUY	$189.21 - $243.2 $210,212 - $270,195	1,111 Added 22.47%	6,056 $1.46 Million
Q3 2019 Nov 07, 2019	SELL	$174.11 - $208.62 $183,686 - $220,094	-1,055 Reduced 17.58%	4,945 $957,000
Q2 2019 Jul 25, 2019	SELL	$166.7 - $195.41 $115,689 - $135,614	-694 Reduced 10.37%	6,000 $1.11 Million
Q1 2019 May 10, 2019	BUY	$180.87 - $203.88 $230,609 - $259,947	1,275 Added 23.53%	6,694 $1.04 Million
Q4 2018 Jan 31, 2019	SELL	$178.4 - $208.25 $98,120 - $114,537	-550 Reduced 9.21%	5,419 $1.06 Million
Q3 2018 Nov 09, 2018	SELL	$185.29 - $208.89 $14,452 - $16,293	-78 Reduced 1.29%	5,969 $1.19 Million
Q2 2018 Aug 14, 2018	BUY	$166.05 - $186.51 $94,980 - $106,683	572 Added 10.45%	6,047 $1.12 Million
Q1 2018 May 15, 2018	SELL	$169.43 - $198.0 $113,009 - $132,066	-667 Reduced 10.86%	5,475 $933,000
Q4 2017 Feb 13, 2018	BUY	$168.79 - $188.59 $16,879 - $18,859	100 Added 1.66%	6,142 $1.07 Million
Q3 2017 Nov 13, 2017	BUY	$167.29 - $191.0 $1.01 Million - $1.15 Million	6,042	6,042 $1.13 Million

Others Institutions Holding AMGN

# of Institutions

3,119

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $152B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hcr Wealth Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Hcr Wealth Advisors with notifications on news.

Account

Hcr Wealth Advisors Amgen Inc Transaction History